General Information
Revision date
2014-09-10
Product name
NovoEight 250, 500. 1000, 1500,
CAS No.
1192451-26-5
Emergency telephone
+45 44 44 88 88, +45 44 49 05 55
Icons in SDS
Company Information
company name
Novo Nordisk A/S
Section 2
SECTION 2: Hazards identification
Emergency telephone +45 44 42 00 00 Email adresse: compliance-team@novonordisk.com The product shall not be classified as hazardous according to (EC) No. 1272 / 2008, EU GHS/ CLP.
Additional information
No special risk if used in accordance with the instructions of the supplier. NovoEight is indicated for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VII or Factor IX.
